New research has found that patients who developed inflammation of the heart, or myocarditis, after receiving an mRNA vaccine for COVID-19 had fewer complications in the 18 months after hospitalization than those who developed it from contracting COVID-19 or some other cause.
The population study, conducted in France and published online Monday in JAMA, found that hospital readmission rates, diagnoses of other heart-related conditions, or instances of death were significantly lower in the group that received the vaccine.
The long-term effects of COVID-19 and COVID-19 vaccines are a concern for the U.S. military, which saw nearly 500,000 cases of the coronavirus in the first two years of the pandemic and required all members to get the vaccine.
Read Next: Arlington Cemetery Confirms ‘Incident’ with Trump Staff as Campaign Denies Physical Fight
The study findings were the same regardless of age, according to the research, although the authors noted that post-vaccine myocarditis patients, who were mainly healthy young men, “may require medical management up to several months after hospital discharge.”
“Although patients with myocarditis after COVID-19 mRNA vaccination appear to have a good prognosis near hospital discharge, their longer-term prognosis and management remain unknown,” wrote the researchers, led by Laura Semenzato, a statistician with EPI-PHARE Scientific Interest Group.
The Defense Department vaccinated more than…
